Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06523868
NA
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Sponsor: Dana-Farber Cancer Institute
View on ClinicalTrials.gov
Summary
The purpose of this research study is to evaluate the possible benefits of an investigational, but commercially available Galleri multi-cancer early detection (MCED) blood test which is designed to detect many types of cancer early in veterans who have served in the military in active duty. The name of the screening blood test being studied is: -GRAIL Galleri MCED test
Key Details
Gender
All
Age Range
45 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1500
Start Date
2025-03-31
Completion Date
2028-09-30
Last Updated
2026-02-27
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
GRAIL Galleri
A multi-cancer early detection (MCED) blood test.
Locations (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States